Despite propensity-score matching and two complementary post-PSM analyses (a diabetes-severity model and an active-comparator design), platform constraints on the number of covariates and unmeasured factors mean that residual biasincluding potential immortal-time/time-origin biascannot be entirely excluded
[email protected] | To view or add a comment, sign in Novo Nordisk partners with Vivtex in up to $2.1 billion deal for oral obesity drugs: Feb 25 (Reuters) - Danish drugmaker Novo Nordisk has partnered with U.S.-based Vivtex Corp in a deal worth up to $2.1 billion to develop next-generation oral drugs for obesity and diabetes, the #NovoNordisk #Vivtex #ObesityTreatment #DiabetesCare #Pharmaceuticals To view or add a comment, sign in Head-to-head trials are often reserved for approved therapies as drugmakers try to one-up each other to gain further market share
Chromatographic analysis of the GSH-OPA abduct was performed using reverse-phase chromatography on Agilent 1200 HPLC (Agilent Technologies, Stockport, UK) with G1311a Quaternary pump, G1367a Autosampler (5 L injection), G1316a Column Compartment (37 C) G1321B Fluorescent light detector, fitted with Phenomenex Gemini C18 100X2 mm and an additional guard column (Phenomenex, Macclesfield, UK) and a stepwise solvent gradient of 25 mM NaH 2 PO 4 (pH 6.0) and acetonitrile as the mobile phase
This hormone plays a key role in controlling blood sugar, slowing digestion, and helping you feel full after eating
It's also a good idea to forego white bread and butter
Our affordable prices include a medical consultation at no extra cost
